EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Direct endoscopic necrosectomy: Pilot study of a new dedicated device

Dario Ligresti iD, Cecilia Binda iD, Alessandro Fugazza, Marcello Maida iD, Mario Traina, Andrea Anderloni iD, Carlo Fabbri, Ilaria Tarantino

Endoscopy International Open · 2024-08 · 12 (08) · E962-E967

DOI: 10.1055/a-2376-1913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, 2024-08. Verfasst von Dario Ligresti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Endoscopy Service, Department of Diagnostic and Therapeutic Services, IRCCS-ISMETT, Palermo, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Italian Health Ministry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and study aims Direct endoscopic necrosectomy (DEN) represents the first-line treatment for walled-off necrosis (WON). However, DEN has a non-negligible rate of overall adverse events (AE) and is time-consuming due to the lack of dedicated devices. This pilot study was designed to evaluate the feasibility and safety of a novel dedicated device for DEN named Necrolit. Patients and methods In this multicenter retrospective analysis,16 patients with WON who underwent DEN using Necrolit were compared with a control group treated with non-dedicated devices. Technical success, AEs, clinical success, number of procedures per patient, procedure time, and length of hospital stay were evaluated. Necrolit technical performance indicators were also studied.

Results

Technical success was obtained in all patients in both groups. In the Necrolit group, the overall AE rate was 10.1% vs. 15.9% in the control group. Clinical success was 100% in the Necrolit group vs. 81.3% in the control group. Patients treated with Necrolit underwent a slightly lower mean number of procedures (4.1 ± 2.3 vs. 5.1 ± 1.9) with comparable mean procedure time (67.8 ± 39 minutes vs. 70.1 ± 32.6 minutes). Mean duration of hospital stay was 39.4 days (± 30.9) in the Necrolit group vs. 43 days (± 29.4) in the control group. Device-related technical performance was rated positively.

Conclusions

DEN with Necrolit appears feasible and safe.

Schlagwörter

Stichwörter der Autor:innen

Endoscopic ultrasonographyIntervention EUSPancreas

Autor:innen und Institutionen

  • Digestive Endoscopy Service, Department of Diagnostic and Therapeutic Services, IRCCS-ISMETT, Palermo, Italy.
  • Unit of Gastroenterology and Digestive Endoscopy, Morgagni-Pierantoni Hospital, Forli, Italy.
  • Unit of Gastroenterology and Digestive Endoscopy, Maurizio Bufalini Hospital, Cesena, Italy.
  • Digestive Endoscopy Unit, Division of Gastroenterology, Humanitas Research Hospital, Rozzano, Italy.
  • Department of Medicine and Surgery, Università degli Studi di Enna 'Kore', Enna, Italy.
  • Gastroenterology Unit, Umberto I Hospital, Enna, Italy.

ORCID-Profile: Dario Ligresti, Cecilia Binda, Marcello Maida, Andrea Anderloni

Förderung

  • Italian Health Ministry

Zitieren

APA

Ligresti, D., Binda, C., Fugazza, A., Maida, M., Traina, M., Anderloni, A., Fabbri, C., & Tarantino, I. (2024). Direct endoscopic necrosectomy: Pilot study of a new dedicated device. Endoscopy International Open, 12(08), E962-E967. https://doi.org/10.1055/a-2376-1913

Vancouver

Ligresti D, Binda C, Fugazza A, Maida M, Traina M, Anderloni A, et al. Direct endoscopic necrosectomy: Pilot study of a new dedicated device. Endoscopy International Open. 2024;12(08):E962-E967. doi:10.1055/a-2376-1913

BibTeX
@article{Ligresti2024,
  author = {Ligresti, Dario and Binda, Cecilia and Fugazza, Alessandro and Maida, Marcello and Traina, Mario and Anderloni, Andrea and Fabbri, Carlo and Tarantino, Ilaria},
  title = {Direct endoscopic necrosectomy: Pilot study of a new dedicated device},
  journal = {Endoscopy International Open},
  year = {2024},
  volume = {12},
  number = {08},
  pages = {E962--E967},
  doi = {10.1055/a-2376-1913}
}
Kostenlos starten →